<?xml version="1.0" encoding="UTF-8" ?><rss 
        version         = "2.0"
        xmlns:content   = "http://purl.org/rss/1.0/modules/content/"
        xmlns:wfw       = "http://wellformedweb.org/CommentAPI/"
        xmlns:dc        = "http://purl.org/dc/elements/1.1/"
        xmlns:atom      = "http://www.w3.org/2005/Atom"
        xmlns:sy        = "http://purl.org/rss/1.0/modules/syndication/"
        xmlns:slash     = "http://purl.org/rss/1.0/modules/slash/"
        type            = "0"
                >
        <channel><item post_id='50297'><title>Der Atrial-Flow Regulator (AFR) von Occlutech erhält die &#8222;Breakthrough Device Designation&#8220; der FDA</title><link>https://business24.ch/2021/01/20/der-atrial-flow-regulator-afr-von-occlutech-erhaelt-die-breakthrough-device-designation-der-fda/</link><pubDate>Wed, 20 Jan 2021 07:00:03 +0000</pubDate>		<category><![CDATA[Presseportal]]></category>
		<category><![CDATA[noinjection]]></category>
<guid isPermalink='false'>https://business24.ch/?p=50297</guid><post-id xmlns="com-wordpress:feed-additions:1">50297</post-id></item></channel>
      </rss>